Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 🚀 Next stop: hashtag#TCT2024 in Washington, DC! 🌐
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Oct 23, 2024 7:16pm
35 Views
Post# 36279405

RE:🚀 Next stop: hashtag#TCT2024 in Washington, DC! 🌐

RE:🚀 Next stop: hashtag#TCT2024 in Washington, DC! 🌐Remember maybe news #TCT2024 in Washington, DC!
The BEST automation and analysis of the PLANET GEN3EHO
Team Connection at Ventripoint: A Meeting to Remember!

Thrilled with the energy from our visit to Ventripoint Diagnostics Ltd. Headquarters in Toronto!

Our visit was not only productive but also incredibly inspiring. From brainstorming sessions to strategic meetings, we dove deep into collaborative talks that are sure to shape the future of pediatric cardiology.

A huge shout-out to everyone at Ventripoint for the warm welcome and the engaging exchanges. We're excited about the partnerships we're fostering and the shared vision we're bringing to life.

Here's to more fruitful meetings and to the success that comes from working together!

Angiopro Ventripoint VMS PediatricCardiology Pediatric Collaboration HealthcareInnovation AngioproMeetsVentripoint

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities